ID2 (Inhibitor Of DNA Binding 2, Dominant Negative Helix-Loop-Helix Protein)
2014-06-01 Menno C van Zelm   AffiliationDept Immunology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands
DNA/RNA

Description
The gene spans 5608 bp containing 5 exons of which 2 (exons 3 and 4) are protein-encoding.
Transcription
The ID2 gene has 4 transcripts, of which 3 can generate functional protein: ID2-001 (2041bp) contains all 5 exons, ID2-201 (1362 bp) contains 3 exons and ID2-002 contains 2 exons. ID2-003 (474 bp) contains a retained intron.
Pseudogene
A pseudogene of ID2 is located on chromosome 3.
Proteins
Description
ID2 belongs to the helix-loop-helix (HLH) protein family. It is composed by 134 aa and belongs to a subgroup HLH family members (ID1, ID2, ID3, ID4) that lack a basic DNA-binding domain. ID proteins form heterodimers with class I basic HLH-group members such as MyoD (Langlands et al., 1997), NEDD9 (Law et al., 1999), and E2A gene products E12 and E47. ID2 has a main domain located on 38-79 aa responsible for the helix-loop-helix conformation. In addition, Id2 contains a 10 aa motif that is responsible for the nuclear export signaling.
Expression
Expression of ID2 is found in the brain, ovary, liver, lung, thyroid gland and prostate and several subsets of leukocytes. ID2 expression is especially high in Natural Killer (NK-) cells, but is also found in CD4+ T cells, CD8+ T cells, monocytes and precursor B cells.
Localisation
Nucleus.
Function
Although it does not bind directly to DNA, by binding basic helix-loop-helix transcription factors through its HLH motif, ID2 may control tissue-specific genes related to cell growth, proliferation and differentiation (Hara et al., 1994; Iavarone et al., 1994). ID2 functions in cell fate decisions in early leukocyte development. Specifically, ID2 is required for NK-cell, innate lymphoid and lymphoid tissue inducer cells (Boos et al., 2007; Moro et al., 2010; Yokota et al., 1999). Furthermore, ID2 functions in the development of several dendritic cell subsets: Langerhans cells, cutaneous dendritic cells and splenic CD8a+ dendritic cells (Hacker et al., 2003). Although ID2 seems redundant for T-cell development in thymus, ID2 promotes NKT-cell development (Verykokakis et al., 2013), and it is involved in effector differentiation (Masson et al., 2013), as well as γδT cell homeostasis (Zhang et al., 2014). Finally, ID2 inhibits progression of precursor-B-cell development (Hara et al., 1997; Jensen et al., 2013), as well as activation-induced deaminase expression during B-cell responses (Gonda et al., 2003), likely through inhibition of E47 (Sayegh et al., 2003).
Besides leukocytes, ID2 has been found to function in erythrocyte development (Ji et al., 2008), enterocyte precursor and lung epithelial cell differentiation in mice (Rawlins et al., 2009). Furthermore, female mice lacking ID2 show lactation defects (Mori et al., 2000), and male mice have impaired spermatogenesis (Sablitzky et al., 1998).
Besides leukocytes, ID2 has been found to function in erythrocyte development (Ji et al., 2008), enterocyte precursor and lung epithelial cell differentiation in mice (Rawlins et al., 2009). Furthermore, female mice lacking ID2 show lactation defects (Mori et al., 2000), and male mice have impaired spermatogenesis (Sablitzky et al., 1998).
Homology
ID2 is highly conserved in vertebrates, including mammals, reptiles, and fish.
Mutations
Germinal
No germinal mutations have been reported.
Somatic
No somatic mutations have been reported.
Implicated in
Entity name
Neuroblastoma
Note
ID2 functions as a key regulator in the phenotypic transition of neuroblastoma tumor cells (Chakrabarti et al., 2013). Anchorage-dependent (AD) neuroblastoma cells express much higher levels of ID2 than anchorage-independent (AI) cells. Moreover, knockdown of ID2 in AD cells induces an AI phenotype, whereas the opposite is seen upon forced expression of ID2 in AI cells. The function of ID2 in this process is at least in part via negative regulation of the TGFβ/Smad pathway.
Entity name
Colon carcinoma
Note
ID2 expression is upregulated by enhanced beta-catenin signaling and subsequent beta-catenin /TCF mediated transcription. The induction of ID2 expression increases anchorage-independent survival of these cells (Rockman et al., 2001).
Entity name
Melanoma
Note
The transition of melanoma to a more aggressive malignancy is associated with the resistance to growth inhibition by TGF-β (Javelaud et al., 2008). In susceptible cells, TGF-β suppresses ID2 expression and allows p15lnk4b to induce a cell cycle arrest (Schlegel et al., 2009). Upon obtaining resistance to TGF-β, the tumor cells overexpress ID2 and remain in cycle.
Entity name
Retinoblastoma
Note
ID2 is overexpressed due to transcriptional activation by oncoproteins of the Myc family in retinoblastoma, where it is thought to inhibit Retinoblastoma protein family members (Lasorella et al., 2000; Lasorella et al., 2005).
Entity name
Note
The majority of Hodgkins lymphomas are derived from germinal center B cells. Still, Hodgkin-Reed/Sternberg (HRS) cells of classical Hodgkins lymphoma have a very atypical phenotype. This is the result of overexpression of ABF-1 and Id2, which inhibit the function of the B cell-determining transcription factor E2A (Mathas et al., 2006; Renne et al., 2006). The mechanism resulting in ID2 overexpression, nor the impact of ID2 on cell cycle progression in HRS cells have been demonstrated experimentally yet (Cotta and Medeiros, 2008).
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 17452521 | 2007 | Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. | Boos MD et al |
| 24376712 | 2013 | A mechanism linking Id2-TGFβ crosstalk to reversible adaptive plasticity in neuroblastoma. | Chakrabarti L et al |
| 18418090 | 2008 | Expression of helix-loop-helix proteins in classical hodgkin lymphoma: a possible explanation for a characteristic immunophenotype. | Cotta CV et al |
| 14581609 | 2003 | The balance between Pax5 and Id2 activities is the key to AID gene expression. | Gonda H et al |
| 12598895 | 2003 | Transcriptional profiling identifies Id2 function in dendritic cell development. | Hacker C et al |
| 9029153 | 1997 | Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors. | Hara E et al |
| 8294468 | 1994 | Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. | Hara E et al |
| 7926730 | 1994 | The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. | Iavarone A et al |
| 18426405 | 2008 | Transforming growth factor-beta in cutaneous melanoma. | Javelaud D et al |
| 23825313 | 2013 | Increased ID2 levels in adult precursor B cells as compared with children is associated with impaired Ig locus contraction and decreased bone marrow output. | Jensen K et al |
| 18523151 | 2008 | Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins. | Ji M et al |
| 9242638 | 1997 | Differential interactions of Id proteins with basic-helix-loop-helix transcription factors. | Langlands K et al |
| 15831462 | 2005 | Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice. | Lasorella A et al |
| 10502414 | 1999 | Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain. | Law SF et al |
| 23536629 | 2013 | Id2-mediated inhibition of E2A represses memory CD8+ T cell differentiation. | Masson F et al |
| 16369535 | 2006 | Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. | Mathas S et al |
| 11060028 | 2000 | Lactation defect in mice lacking the helix-loop-helix inhibitor Id2. | Mori S et al |
| 20023630 | 2010 | Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. | Moro K et al |
| 19855016 | 2009 | The Id2+ distal tip lung epithelium contains individual multipotent embryonic progenitor cells. | Rawlins EL et al |
| 16877363 | 2006 | Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. | Renné C et al |
| 11572874 | 2001 | Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. | Rockman SP et al |
| 9869302 | 1998 | Stage- and subcellular-specific expression of Id proteins in male germ and Sertoli cells implicates distinctive regulatory roles for Id proteins during meiosis, spermatogenesis, and Sertoli cell function. | Sablitzky F et al |
| 12717431 | 2003 | E-proteins directly regulate expression of activation-induced deaminase in mature B cells. | Sayegh CE et al |
| 19368689 | 2009 | Id2 suppression of p15 counters TGF-beta-mediated growth inhibition of melanoma cells. | Schlegel NC et al |
| 24244015 | 2013 | Essential functions for ID proteins at multiple checkpoints in invariant NKT cell development. | Verykokakis M et al |
| 10067894 | 1999 | Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. | Yokota Y et al |
| 24379125 | 2014 | Id3 and Id2 act as a dual safety mechanism in regulating the development and population size of innate-like γδ T cells. | Zhang B et al |
Other Information
Locus ID:
NCBI: 3398
MIM: 600386
HGNC: 5361
Ensembl: ENSG00000115738
Variants:
dbSNP: 3398
ClinVar: 3398
TCGA: ENSG00000115738
COSMIC: ID2
RNA/Proteins
Expression (GTEx)
Pathways
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38422912 | 2024 | Prediction of the binding location between the nuclear inhibitor of DNA binding and differentiation 2 (ID2) and HSPA5. | 0 |
| 38422912 | 2024 | Prediction of the binding location between the nuclear inhibitor of DNA binding and differentiation 2 (ID2) and HSPA5. | 0 |
| 37497010 | 2023 | SMURF2 facilitates ubiquitin-mediated degradation of ID2 to attenuate lung cancer cell proliferation. | 0 |
| 37497010 | 2023 | SMURF2 facilitates ubiquitin-mediated degradation of ID2 to attenuate lung cancer cell proliferation. | 0 |
| 35078502 | 2022 | LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c. | 6 |
| 35149717 | 2022 | ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation. | 9 |
| 35422476 | 2022 | Inhibitor of DNA binding 2 (ID2) regulates the expression of developmental genes and tumorigenesis in ewing sarcoma. | 3 |
| 35583063 | 2022 | [Increased expression of inhibitor of differentiation 2 (Id2) in CD4(+)T cells in joint synovial fluid of patients with rheumatoid arthritis]. | 0 |
| 35604218 | 2022 | KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle. | 3 |
| 35608547 | 2022 | Temporal Expression of Transcription Factor ID2 Improves Natural Killer Cell Differentiation from Human Pluripotent Stem Cells. | 3 |
| 35701409 | 2022 | ID proteins promote the survival and primed-to-naive transition of human embryonic stem cells through TCF3-mediated transcription. | 3 |
| 35705978 | 2022 | GDF-11 promotes human trophoblast cell invasion by increasing ID2-mediated MMP2 expression. | 7 |
| 35078502 | 2022 | LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c. | 6 |
| 35149717 | 2022 | ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation. | 9 |
| 35422476 | 2022 | Inhibitor of DNA binding 2 (ID2) regulates the expression of developmental genes and tumorigenesis in ewing sarcoma. | 3 |
Citation
Menno C van Zelm
ID2 (Inhibitor Of DNA Binding 2, Dominant Negative Helix-Loop-Helix Protein)
Atlas Genet Cytogenet Oncol Haematol. 2014-06-01
Online version: http://atlasgeneticsoncology.org/gene/436/id2-(inhibitor-of-dna-binding-2-dominant-negative-helix-loop-helix-protein)
